OTHER GROUP COMPANIES
market

Supriya Lifescience standalone net profit declines 4.74% in the March 2022 quarter

Sales rise 37.21% to Rs 181.27 crore

May 20, 2022 5:38 IST | capital market
Net profit of Supriya Lifescience declined 4.74% to Rs 46.21 crore in the quarter ended March 2022 as against Rs 48.51 crore during the previous quarter ended March 2021. Sales rose 37.21% to Rs 181.27 crore in the quarter ended March 2022 as against Rs 132.11 crore during the previous quarter ended March 2021. For the full year,net profit rose 22.83% to Rs 151.81 crore in the year ended March 2022 as against Rs 123.59 crore during the previous year ended March 2021. Sales rose 35.48% to Rs 530.05 crore in the year ended March 2022 as against Rs 391.25 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear Ended
?Mar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.
Sales181.27132.11 37 530.05391.25 35
OPM %41.5050.84 -40.3744.26 -
PBDT78.0767.43 16 217.37174.07 25
PBT75.4965.65 15 207.25167.31 24
NP46.2148.51 -5 151.81123.59 23
Powered by Capital Market - Live News

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity